Ubs Asset Management Americas Inc Castle Biosciences Inc Transaction History

Ubs Asset Management Americas Inc

  • $381 Billion
  • Q3 2024

A detailed history of Ubs Asset Management Americas Inc transactions in Castle Biosciences Inc stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 55,532 shares of CSTL stock, worth $1.55 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
55,532
Previous 56,136 1.08%
Holding current value
$1.55 Million
Previous $1.22 Million 29.54%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$17.4 - $31.47 $10,509 - $19,007
-604 Reduced 1.08%
55,532 $1.58 Million
Q2 2024

Aug 13, 2024
BUY
$18.84 - $24.94 $458,716 - $607,239
24,348 Added 76.59%
56,136 $1.22 Million
Q1 2024

May 15, 2024
BUY
$18.06 - $25.3 $81,757 - $114,533
4,527 Added 16.61%
31,788 $704,000
Q3 2023

Nov 13, 2023
SELL
$13.28 - $20.3 $1.73 Million - $2.64 Million
-130,061 Reduced 82.67%
27,261 $460,000
Q1 2023

May 15, 2023
SELL
$19.47 - $28.49 $33,897 - $49,601
-1,741 Reduced 1.09%
157,322 $3.57 Million
Q4 2022

Feb 14, 2023
BUY
$18.08 - $30.0 $229,923 - $381,510
12,717 Added 8.69%
159,063 $3.74 Million
Q3 2022

Nov 14, 2022
SELL
$22.51 - $34.32 $243,243 - $370,861
-10,806 Reduced 6.88%
146,346 $3.82 Million
Q2 2022

Aug 12, 2022
SELL
$16.0 - $45.99 $330,864 - $951,027
-20,679 Reduced 11.63%
157,152 $3.45 Million
Q1 2022

May 16, 2022
SELL
$33.17 - $46.98 $312,196 - $442,175
-9,412 Reduced 5.03%
177,831 $7.98 Million
Q4 2021

Feb 14, 2022
BUY
$39.06 - $67.58 $335,447 - $580,377
8,588 Added 4.81%
187,243 $8.03 Million
Q3 2021

Nov 15, 2021
SELL
$60.13 - $77.6 $490,179 - $632,595
-8,152 Reduced 4.36%
178,655 $11.9 Million
Q2 2021

Aug 16, 2021
SELL
$50.07 - $76.78 $339,023 - $519,877
-6,771 Reduced 3.5%
186,807 $13.7 Million
Q1 2021

May 14, 2021
BUY
$58.92 - $97.33 $200,917 - $331,895
3,410 Added 1.79%
193,578 $13.3 Million
Q4 2020

Mar 01, 2021
SELL
$43.6 - $73.05 $3.01 Million - $5.04 Million
-68,969 Reduced 26.61%
190,168 $12.8 Million
Q3 2020

Nov 13, 2020
BUY
$38.47 - $52.03 $3.66 Million - $4.95 Million
95,058 Added 57.93%
259,137 $13.3 Million
Q2 2020

Aug 14, 2020
BUY
$27.28 - $43.01 $231,825 - $365,498
8,498 Added 5.46%
164,079 $6.18 Million
Q1 2020

May 15, 2020
BUY
$23.08 - $35.53 $3.59 Million - $5.53 Million
155,581 New
155,581 $4.64 Million

Others Institutions Holding CSTL

# of Institutions
206
Shares Held
27.1M
Call Options Held
278K
Put Options Held
30.3K
View Full List

About CASTLE BIOSCIENCES INC

CSTL Quotes by TradingView
  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $732M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email